Agro-economic prospects for expanding soybean production beyond its current northerly limit in Europe

Soybean is one of the five crops that dominate global agriculture, along with maize, wheat, cotton and rice. In Europe, soybean still plays a minor role and is cultivated mainly in the South and East. Very little is known about the potential for soybean in higher latitudes with relatively cool conditions. To investigate the agronomic potential and limitations of soybean for feed (high grain yield) and food (high protein content, e.g., for tofu production) in higher latitudes, an organic soybean cropping system experiment was carried out from 2015 to 2017 in northeastern Germany. The objectives were: (1) to identify food- and feed-grade soybean cultivars that are adapted to a central European climate in terms of protein, grain yield, and yield stability, (2) to explore the effect of irrigation on soybean protein and grain yield under relatively dry growing conditions, and (3) to determine the agro-economic potential of soybean cultivation for both feed and food markets. Three soybean cultivars were tested with and without irrigation. The soybean feed-grade cultivars 'Sultana' and 'Merlin' were better adapted to the growing cycle and temperature, providing higher and more stable yields (average 2700 kg ha(-1)) than the food-grade cultivar 'Protibus' (average 1300 kg ha(-1)). Irrigation increased soybean grain yields by 41% on average. In the year with sufficient precipitation, no additional irrigation was necessary. Gross margins of organic soybean ranged between 750 (sic) ha(-1) for the rainfed food-grade soybean and 2000 (sic) ha(-1) for the irrigated feed-grade soybean and were higher than other crops. We demonstrated a large agro-economic potential for soybean as a novel grain legume crop to diversify cropping systems and increase the production of protein crops in central Europe.Peer reviewe

Comparing a Modified Dry By-product to Dry Distillers Grains with Solubles in Growing Calf Diets

A growing trial was conducted to contrast a new by-product, Dakota Bran Cake (DBRAN), against dry distillers grains with solubles (DDGS) and evaluate the two by-products at two dietary inclusion levels on steer calf performance measurements. Diet treatments included 15% DBRAN, 30% DBRAN, 15% DDGS, and 30% DDGS, replacing a blend (70:30 ratio) of brome grass hay and alfalfa haylage (DM basis). Final BW, ADG, and DMI increased, while F:G decreased as the inclusion level for both of these by-products increased from 15 to 30% DM. DDGS significantly improved ADG and F:G compared to feeding DBRAN at both inclusion levels. Feeding DBRAN and DDGS in growing diets to steer calves improved performance at higher dietary inclusion levels, while DDGS tended to improve performance over DBRAN

Evaluation of Dry Distillers Grains Plus Solubles Inclusion on Performance and Economics of Finishing Beef Steers

A 167-d feedlot study was conducted to evaluate feeding increasing levels of dry distillers grains plus solubles (DDGS) to finishing cattle and the impact on performance and profitability. Crossbred steer calves (n = 240, BW = 306 ± 24.5 kg) were used in 30 pens with dietary treatments of 0, 10, 20, 30, and 40% DDGS dietary inclusion (DM basis). Quadratic relationships (P \u3c 0.05) were observed for final BW and ADG as dietary DDGS increased, with the greatest ADG observed at 20% inclusion. The DMI was not affected (P \u3e 0.15) by DDGS level, but G:F tended to be quadratic (P = 0.10) as 20% DM inclusion had the greatest value, although steers fed all levels of DDGS had numerically greater G:F compared with steers fed no DDGS. Carcass characteristics, other than hot carcass weight, were not affected by DDGS treatment. Energy value of DDGS at 10 to 40% dietary inclusion resulted in a quadratic trend (P = 0.10) and remained above corn, with the highest values at 10 and 20% inclusion averaging 127% of corn. When DDGS was priced equally to corn, all levels of DDGS from 10 to 40% inclusion resulted in higher profits compared with a dry-rolled corn based diet regardless of corn price. The greatest returns were observed when cattle were fed 20% DDGS. These data indicate that DDGS can be fed up to 40% DM to improve cattle performance and result in economic profits, with optimum levels at 20 to 30% diet DM

Evaluation of Dry Distillers Grains Plus Solubles Inclusion on Performance and Economics of Finishing Beef Steers

A 167-d feedlot study was conducted to evaluate feeding increasing levels of dry distillers grains plus solubles (DDGS) to finishing cattle and the impact on performance and profitability. Crossbred steer calves (n = 240, BW = 306 ± 24.5 kg) were used in 30 pens with dietary treatments of 0, 10, 20, 30, and 40% DDGS dietary inclusion (DM basis). Quadratic relationships (P \u3c 0.05) were observed for final BW and ADG as dietary DDGS increased, with the greatest ADG observed at 20% inclusion. The DMI was not affected (P \u3e 0.15) by DDGS level, but G:F tended to be quadratic (P = 0.10) as 20% DM inclusion had the greatest value, although steers fed all levels of DDGS had numerically greater G:F compared with steers fed no DDGS. Carcass characteristics, other than hot carcass weight, were not affected by DDGS treatment. Energy value of DDGS at 10 to 40% dietary inclusion resulted in a quadratic trend (P = 0.10) and remained above corn, with the highest values at 10 and 20% inclusion averaging 127% of corn. When DDGS was priced equally to corn, all levels of DDGS from 10 to 40% inclusion resulted in higher profits compared with a dry-rolled corn based diet regardless of corn price. The greatest returns were observed when cattle were fed 20% DDGS. These data indicate that DDGS can be fed up to 40% DM to improve cattle performance and result in economic profits, with optimum levels at 20 to 30% diet DM

Recovery of Endogenous β-Cell Function in Nonhuman Primates After Chemical Diabetes Induction and Islet Transplantation

OBJECTIVE—To describe the ability of nonhuman primate endocrine pancreata to reestablish endogenous insulin production after chemical β-cell destruction

Insulin detemir in a twice daily insulin regimen versus a three times daily insulin regimen in the treatment of type 1 diabetes in children: A pilot randomized controlled trial

Article deposited according to agreement with BMC, December 6, 2010.YesFunding provided by the Open Access Authors Fund

Effect of Bio-Oss® Collagen and Collagen Matrix on Bone Formation

Objective: to compare the amount of new bone produced by Bio-Oss ® Collagen to that produced by collagen matrix in vivo. Method: eighteen bone defects, 5mm by 10mm were created in the parietal bone of 9 New Zealand White rabbits. 6 defects were grafted with Bio-Oss ® Collagen. 6 defects were grafted with collagen matrix alone (positive control) and 6 were left empty (negative control). Animals were killed on day 14 and the defects were dissected and prepared for histological assessment. Quantitative analysis of new bone formation was made on 100 sections (50 sections for each group) using image analysis. Results: A total of 339% more new bone was present in defects grafted with Bio-Oss ® Collagen than those grafted with collagen matrix (positive control). No bone was formed in the negative control group. Conclusion: Bio-Oss ® Collagen has the effect of stimulating new bone formation locally compared with collagen matrix in vivo. Bio-Oss ® Collagen may be utilized as a bone graft material. © Wong and Rabie; Licensee Bentham Open.published_or_final_versio

Increased DNA methylation variability in type 1 diabetes across three immune effector cell types

The incidence of type 1 diabetes (T1D) has substantially increased over the past decade, suggesting a role for non-genetic factors such as epigenetic mechanisms in disease development. Here we present an epigenome-wide association study across 406,365 CpGs in 52 monozygotic twin pairs discordant for T1D in three immune effector cell types. We observe a substantial enrichment of differentially variable CpG positions (DVPs) in T1D twins when compared with their healthy co-twins and when compared with healthy, unrelated individuals. These T1D-associated DVPs are found to be temporally stable and enriched at gene regulatory elements. Integration with cell type-specific gene regulatory circuits highlight pathways involved in immune cell metabolism and the cell cycle, including mTOR signalling. Evidence from cord blood of newborns who progress to overt T1D suggests that the DVPs likely emerge after birth. Our findings, based on 772 methylomes, implicate epigenetic changes that could contribute to disease pathogenesis in T1D.This work was funded by the EU-FP7 project BLUEPRINT (282510) and the Wellcome Trust (99148). We thank all twins for taking part in this study; Kerra Pearce and Mark Kristiansen (UCL Genomics) for processing the Illumina Infinium HumanMethylation450 BeadChips; Rasmus Bennet for technical assistance; and Laura Phipps for proofreading the manuscript. The BMBF Pediatric Diabetes Biobank recruits patients from the National Diabetes Patient Documentation System (DPV), and is financed by the German Ministry of Education and Research within the German Competence Net Diabetes Mellitus (01GI1106 and 01GI1109B). It was integrated into the German Center for Diabetes Research in January 2015. We thank the Swedish Research Council and SUS Funds for support. We gratefully acknowledge the participation of all NIHR Cambridge BioResource volunteers, and thank the Cambridge BioResource staff for their help with volunteer recruitment. We thank members of the Cambridge BioResource SAB and Management Committee for their support of our study and the NIHR Cambridge Biomedical Research Centre for funding. The Cardiovascular Epidemiology Unit is supported by the UK Medical Research Council (G0800270), BHF (SP/09/002), and NIHR Cambridge Biomedical Research Centre. Research in the Ouwehand laboratory is supported by the NIHR, BHF (PG-0310-1002 and RG/09/12/28096) and NHS Blood and Transplant. K.D. is funded as a HSST trainee by NHS Health Education England. M.F. is supported by the BHF Cambridge Centre of Excellence (RE/13/6/30180). A.D., E.L., L.C. and P.F. receive additional support from the European Molecular Biology Laboratory. A.K.S. is supported by an ADA Career Development Award (1-14-CD-17). B.O.B. and R.D.L. acknowledge support from the Deutsche Forschungsgemeinschaft (DFG) and European Federation for the Study of Diabetes, respectively

Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual β cell function

Type 1A diabetes mellitus (T1ADM) is a progressive autoimmune disease mediated by T lymphocytes with destruction of beta cells. Up to now, we do not have precise methods to assess the beta cell mass, "in vivo" or "ex-vivo". The studies about its genetic susceptibility show strong association with class II antigens of the HLA system (particularly DQ). Others genetics associations are weaker and depend on the population studied. A combination of precipitating events may occur at the beginning of the disease. There is a silent loss of immune-mediated beta cells mass which velocity has an inverse relation with the age, but it is influenced by genetic and metabolic factors. We can predict the development of the disease primarily through the determination of four biochemically islet auto antibodies against antigens like insulin, GAD65, IA2 and Znt8. Beta cell destruction is chronically progressive but at clinical diagnosis of the disease a reserve of these cells still functioning. The goal of secondary disease prevention is halt the autoimmune attack on beta cells by redirecting or dampening the immune system. It is remains one of the foremost therapeutic goals in the T1ADM. Glycemic intensive control and immunotherapeutic agents may preserve beta-cell function in newly diagnosed patients with T1ADM. It may be assessed through C-peptide values, which are important for glycemic stability and for the prevention of chronic complications of this disease. This article will summarize the etiopathogenesis mechanisms of this disease and the factors can influence on residual C-peptide and the strategies to it preservation